MGC Diagnostics Corp. (NASDAQ: MGCD) Starts Presentation at the 2017 Marcum Microcap Conference
MGC Diagnostics (NASDAQ: MGCD) is a global medical technology company dedicated to cardiorespiratory health solutions. The company develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The company’s products are sold internationally through distributors and, in the United States, France and Belgium, primarily through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians’ offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations. For more information, visit the company's website at mgcdiagnostics.com About NetworkNewsWire…
